Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0391 Transporter Info
Gene Name SLC51A
Transporter Name Organic solute transporter subunit alpha
Gene ID
200931
UniProt ID
Q86UW1
Microbiota Influence of This DT (MBI)

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 13 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 2

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 3

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Cholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 4

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Cholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 5

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Deoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 6

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Deoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 7

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 8

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 9

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Lithocholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 10

 Down regulating of SLC51A expression in the health condition [1] , [2]

Regulating Factor
Bile acid (Lithocholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.

       Microbe Influence 11

 Up regulating of SLC51A expression in the health condition [3]

Regulating Factor
Chenodeoxycholic acid

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Liver

In Vivo Model

 C57BL/6 mice

In Vitro Model

 Human hepatoblastoma cells (HepG2)

Detailed Description

 The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC51A.

       Microbe Influence 12

 Up regulating of SLC51A expression in conventional mice compared with germ-free mice [4] , [5]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Ileum

In Vivo Model

 Swiss Webster mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter SLC51A.

       Microbe Influence 13

 Down regulating of SLC51A expression in conventional mice compared with germ-free mice [6]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Large intestine

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC51A.
References
1 Bile Acids Activated Receptors Regulate Innate Immunity. Front Immunol. 2018 Aug 13;9:1853.
2 Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice. Drug Metab Dispos. 2015 Oct;43(10):1544-56.
3 Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1124-30.
4 Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos. 2015 Oct;43(10):1505-21.
5 Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013 Feb 5;17(2):225-35.
6 RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice. Drug Metab Dispos. 2017 Dec;45(12):1225-1238.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.